What patients need to know about cataract surgery

Podcast

Uday Devgan, MD, FACS, of Devgan Eye Surgery in Los Angeles and Beverly Hills, CA, answers a few key questions his patients have asked when considering cataract surgery.

Listen to more EyePod episodes here

Recent Videos
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
CIME 2024: Neda Shamie, MD, reports on a morning session packed with refractive surgery options, retina, glaucoma, and a 'mite-y' Demodex discussion
Highlights from the 18th Annual Controversies in Modern Eye Care Symposium: Arjan Hura, MD, on Refractive Surgery, Retina Care, and Record Attendance
ASCRS 2024: ViaLase Updates on Nonincisional Glaucoma Treatment Targeting Trabecular Meshwork
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
Related Content
Nicox announces recruitment of last patient in US in Denali Phase 3 trial of NCX 470

Nicox announces recruitment of last patient in US in Denali Phase 3 trial of NCX 470

Article
Ehsan Sadri, MD, leads an ophthalmology innovation discussion with Jeffry Weinhuff of Visionary Ventures

(EyePod) From idea to impact: Navigating ophthalmic innovation

Podcast
Osheru receives funding to advance Ziplyft device for blepharoplasty surgery

Osheru receives funding to advance Ziplyft device for blepharoplasty surgery

Article
EyePod: Integrating cutting-edge pipeline devices for enhanced cataract surgery

EyePod: Integrating cutting-edge pipeline devices for enhanced cataract surgery

Podcast
CHAMP Phase 3 trial: Efficacy of NVK002 for controlling pediatric myopia over 3 years

CHAMP Phase 3 trial: Efficacy of NVK002 for controlling pediatric myopia over 3 years

Article
FDA approves faricimab-svoa 6.0 mg single-dose prefilled syringe for use in the treatment of wet AMD, DME and RVO

FDA approves faricimab-svoa 6.0 mg single-dose prefilled syringe for use in the treatment of wet AMD, DME and RVO

Article
© 2024 MJH Life Sciences

All rights reserved.